BIT Capital’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-60,631
Closed -$1.18M 126
2024
Q3
$1.18M Buy
60,631
+30,447
+101% +$617K 0.11% 64
2024
Q2
$621K Hold
30,184
0.05% 94
2024
Q1
$644K Buy
+30,184
New +$587K 0.05% 100
2022
Q3
Sell
-12,500
Closed -$229K 159
2022
Q2
$229K Hold
12,500
0.03% 89
2022
Q1
$201K Buy
+12,500
New +$181K 0.02% 94

Other funds holding KURA

BIT Capital's KURA Position: Q4 2024 in Review

BIT Capital sold out of Kura Oncology (KURA) in Q4 2024, closing a stake of 60,631 shares — an estimated $1.18M sold.

BIT Capital first reported a position in KURA in Q1 2022 and held it in 5 quarters. The position peaked at $1.18M in Q3 2024. 185 funds tracked by Wall St. Rank hold KURA as of Q4 2024.

  • BIT Capital reported no remaining Kura Oncology position as of Q4 2024 after selling out during the quarter.
  • BIT Capital sold 60,631 Kura Oncology shares in Q4 2024, an estimated $1.18M.
  • BIT Capital first reported a position in Kura Oncology in Q1 2022 and held it in 5 quarters.
  • BIT Capital's Kura Oncology position peaked at $1.18M in Q3 2024.
  • 185 funds tracked by Wall St. Rank held Kura Oncology as of Q4 2024.

Based on BIT Capital's 13F filing for Q4 2024, filed 12 Feb 2025.